{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:17:52Z","timestamp":1790306272210,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1108066, 1140509, 1182086, 1054925, 1175411, 1183478"],"award-info":[{"award-number":["1108066, 1140509, 1182086, 1054925, 1175411, 1183478"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002570","name":"American Association of Immunologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Department of Education and Training | Australian Research Council","doi-asserted-by":"publisher","award":["FT170100174, DP200102776, DP170102020"],"award-info":[{"award-number":["FT170100174, DP200102776, DP170102020"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["825821"],"award-info":[{"award-number":["825821"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["A1106697"],"award-info":[{"award-number":["A1106697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bellberry Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41590-021-01077-y","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T17:03:42Z","timestamp":1638205422000},"page":"86-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection"],"prefix":"10.1038","volume":"23","author":[{"given":"Andrea","family":"Di Pietro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-4128","authenticated-orcid":false,"given":"Jack","family":"Polmear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-4435","authenticated-orcid":false,"given":"Timon","family":"Damelang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabinda","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hailes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibha","family":"Udupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8969-8297","authenticated-orcid":false,"given":"Simon","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areen","family":"Shtewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Hershberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1002-0000","authenticated-orcid":false,"given":"Stephen J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5358-9363","authenticated-orcid":false,"given":"Nicole L.","family":"La Gruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-9704","authenticated-orcid":false,"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-686X","authenticated-orcid":false,"given":"David M.","family":"Tarlinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-8504","authenticated-orcid":false,"given":"Christopher D.","family":"Scharer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1891-7274","authenticated-orcid":false,"given":"Kim L.","family":"Good-Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.cell.2020.10.052","volume":"183","author":"T Zohar","year":"2020","unstructured":"Zohar, T. et al. Compromised humoral functional evolution tracks with SARS-CoV-2 mortality. Cell 183, 1508\u20131519 (2020).","journal-title":"Cell"},{"key":"1077_CR2","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff, M. C. et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 21, 1506\u20131516 (2020).","journal-title":"Nat. Immunol."},{"key":"1077_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/ni.2428","volume":"13","author":"D Dominguez-Sola","year":"2012","unstructured":"Dominguez-Sola, D. et al. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat. Immunol. 13, 1083\u20131091 (2012).","journal-title":"Nat. Immunol."},{"key":"1077_CR4","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/ni.2418","volume":"13","author":"DP Calado","year":"2012","unstructured":"Calado, D. P. et al. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. Nat. Immunol. 13, 1092\u20131100 (2012).","journal-title":"Nat. Immunol."},{"key":"1077_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2019.06.013","volume":"51","author":"S Finkin","year":"2019","unstructured":"Finkin, S., Hartweger, H., Oliveira, T. Y., Kara, E. E. & Nussenzweig, M. C. Protein amounts of the MYC transcription factor determine germinal center B cell division capacity. Immunity 51, 324\u2013336 (2019).","journal-title":"Immunity"},{"key":"1077_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni911","volume":"4","author":"L Hunziker","year":"2003","unstructured":"Hunziker, L. et al. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 4, 343\u2013349 (2003).","journal-title":"Nat. Immunol."},{"key":"1077_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ni1102","volume":"5","author":"M Recher","year":"2004","unstructured":"Recher, M. et al. Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat. Immunol. 5, 934\u2013942 (2004).","journal-title":"Nat. Immunol."},{"key":"1077_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJM198308253090803","volume":"309","author":"HC Lane","year":"1983","unstructured":"Lane, H. C. et al. Abnormalities of B cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309, 453\u2013458 (1983).","journal-title":"N. Engl. J. Med."},{"key":"1077_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/imcb.12338","volume":"98","author":"L Cooper","year":"2020","unstructured":"Cooper, L. & Good-Jacobson, K. L. Dysregulation of humoral immunity in chronic infection. Immunol. Cell Biol. 98, 456\u2013466 (2020).","journal-title":"Immunol. Cell Biol."},{"key":"1077_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2015.01.009","volume":"42","author":"A Wieland","year":"2015","unstructured":"Wieland, A. et al. Antibody effector functions mediated by Fc\u03b3-receptors are compromised during persistent viral infection. Immunity 42, 367\u2013378 (2015).","journal-title":"Immunity"},{"key":"1077_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2015.01.005","volume":"42","author":"DH Yamada","year":"2015","unstructured":"Yamada, D. H. et al. Suppression of Fc\u03b3-receptor-mediated antibody effector function during persistent viral infection. Immunity 42, 379\u2013390 (2015).","journal-title":"Immunity"},{"key":"1077_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1056\/NEJM199302183280711","volume":"328","author":"GB Appel","year":"1993","unstructured":"Appel, G. B. Immune-complex glomerulonephritis\u2013deposits plus interest. N. Engl. J. Med. 328, 505\u2013506 (1993).","journal-title":"N. Engl. J. Med."},{"key":"1077_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.131.1.1","volume":"131","author":"MB Oldstone","year":"1970","unstructured":"Oldstone, M. B. & Dixon, F. J. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. II. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease. J. Exp. Med. 131, 1\u201319 (1970).","journal-title":"J. Exp. Med."},{"key":"1077_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu, L. L., Suscovich, T. J., Fortune, S. M. & Alter, G. Beyond binding: antibody effector functions in infectious diseases. Nat. Rev. Immunol. 18, 46\u201361 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1077_CR15","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/eji.201343565","volume":"43","author":"T Straub","year":"2013","unstructured":"Straub, T. et al. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and Fc\u03b3R. Eur. J. Immunol. 43, 2338\u20132348 (2013).","journal-title":"Eur. J. Immunol."},{"key":"1077_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","volume":"163","author":"AW Chung","year":"2015","unstructured":"Chung, A. W. et al. Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology. Cell 163, 988\u2013998 (2015).","journal-title":"Cell"},{"key":"1077_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","volume":"162","author":"TT Wang","year":"2015","unstructured":"Wang, T. T. et al. Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy. Cell 162, 160\u2013169 (2015).","journal-title":"Cell"},{"key":"1077_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41591-019-0412-8","volume":"25","author":"M Caskey","year":"2019","unstructured":"Caskey, M., Klein, F. & Nussenzweig, M. C. Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic. Nat. Med. 25, 547\u2013553 (2019).","journal-title":"Nat. Med."},{"key":"1077_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/imr.12733","volume":"288","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. & Good-Jacobson, K. L. Epigenetic regulation of B cell fate and function during an immune response. Immunol. Rev. 288, 75\u201384 (2019).","journal-title":"Immunol. Rev."},{"key":"1077_CR20","doi-asserted-by":"publisher","first-page":"108504","DOI":"10.1016\/j.celrep.2020.108504","volume":"33","author":"L Kealy","year":"2020","unstructured":"Kealy, L. et al. The histone methyltransferase DOT1L is essential for humoral immune responses. Cell Rep. 33, 108504 (2020).","journal-title":"Cell Rep."},{"key":"1077_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"Sen, D. R. et al. The epigenetic landscape of T cell exhaustion. Science 354, 1165\u20131169 (2016).","journal-title":"Science"},{"key":"1077_CR22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"1077_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W Beguelin","year":"2013","unstructured":"Beguelin, W. et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23, 677\u2013692 (2013).","journal-title":"Cancer Cell"},{"key":"1077_CR24","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1172\/JCI70626","volume":"123","author":"M Caganova","year":"2013","unstructured":"Caganova, M. et al. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. J. Clin. Invest. 123, 5009\u20135022 (2013).","journal-title":"J. Clin. Invest."},{"key":"1077_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41590-020-0700-y","volume":"21","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. et al. Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity. Nat. Immunol. 21, 950\u2013961 (2020).","journal-title":"Nat. Immunol."},{"key":"1077_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ccell.2016.07.006","volume":"30","author":"W Beguelin","year":"2016","unstructured":"Beguelin, W. et al. EZH2 and BCL6 cooperate to assemble CBX8\u2013BCOR complex to repress bivalent promoters, mediate germinal center formation and lymphomagenesis. Cancer Cell 30, 197\u2013213 (2016).","journal-title":"Cancer Cell"},{"key":"1077_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4049\/jimmunol.164.1.1","volume":"164","author":"FM Raaphorst","year":"2000","unstructured":"Raaphorst, F. M. et al. Cutting edge: Polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J. Immunol. 164, 1\u20134 (2000).","journal-title":"J. Immunol."},{"key":"1077_CR28","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1182\/blood-2002-10-3161","volume":"102","author":"K Tarte","year":"2003","unstructured":"Tarte, K., Zhan, F., De Vos, J., Klein, B. & Shaughnessy, J. Jr. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B cell differentiation. Blood 102, 592\u2013600 (2003).","journal-title":"Blood"},{"key":"1077_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","volume":"20","author":"R Cao","year":"2005","unstructured":"Cao, R., Tsukada, Y. & Zhang, Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20, 845\u2013854 (2005).","journal-title":"Mol. Cell"},{"key":"1077_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nature02985","volume":"431","author":"H Wang","year":"2004","unstructured":"Wang, H. et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431, 873\u2013878 (2004).","journal-title":"Nature"},{"key":"1077_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/16476","volume":"397","author":"JJ Jacobs","year":"1999","unstructured":"Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene BMI-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164\u2013168 (1999).","journal-title":"Nature"},{"key":"1077_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.celrep.2018.12.030","volume":"26","author":"DJ Cantor","year":"2019","unstructured":"Cantor, D. J. et al. Impaired expression of rearranged immunoglobulin genes and premature p53 activation block B cell development in BMI1 null mice. Cell Rep. 26, 108\u2013118 (2019).","journal-title":"Cell Rep."},{"key":"1077_CR33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.20072000","volume":"205","author":"M Yamashita","year":"2008","unstructured":"Yamashita, M. et al. Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J. Exp. Med. 205, 1109\u20131120 (2008).","journal-title":"J. Exp. Med."},{"key":"1077_CR34","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1158\/0008-5472.CAN-09-4229","volume":"70","author":"Z Jagani","year":"2010","unstructured":"Jagani, Z. et al. The Polycomb group protein BMI-1 is essential for the growth of multiple myeloma cells. Cancer Res. 70, 5528\u20135538 (2010).","journal-title":"Cancer Res."},{"key":"1077_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255\u2013260 (2003).","journal-title":"Nature"},{"key":"1077_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.stem.2010.01.005","volume":"6","author":"H Oguro","year":"2010","unstructured":"Oguro, H. et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the Polycomb protein Bmi1. Cell Stem Cell 6, 279\u2013286 (2010).","journal-title":"Cell Stem Cell"},{"key":"1077_CR37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0092-8674(91)90383-A","volume":"65","author":"Y Haupt","year":"1991","unstructured":"Haupt, Y., Alexander, W. S., Barri, G., Klinken, S. P. & Adams, J. M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65, 753\u2013763 (1991).","journal-title":"Cell"},{"key":"1077_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0092-8674(91)90382-9","volume":"65","author":"M van Lohuizen","year":"1991","unstructured":"van Lohuizen, M. et al. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65, 737\u2013752 (1991).","journal-title":"Cell"},{"key":"1077_CR39","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm1614","volume":"13","author":"C Dierks","year":"2007","unstructured":"Dierks, C. et al. Essential role of stromally induced hedgehog signaling in B cell malignancies. Nat. Med. 13, 944\u2013951 (2007).","journal-title":"Nat. Med."},{"key":"1077_CR40","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1038\/sj.onc.1205868","volume":"21","author":"J De Vos","year":"2002","unstructured":"De Vos, J. et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 21, 6848\u20136857 (2002).","journal-title":"Oncogene"},{"key":"1077_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207\u2013211 (2013).","journal-title":"Science"},{"key":"1077_CR42","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.4049\/jimmunol.177.5.3266","volume":"177","author":"J Louten","year":"2006","unstructured":"Louten, J., van Rooijen, N. & Biron, C. A. Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection. J. Immunol. 177, 3266\u20133272 (2006).","journal-title":"J. Immunol."},{"key":"1077_CR43","doi-asserted-by":"publisher","first-page":"8252","DOI":"10.1073\/pnas.88.18.8252","volume":"88","author":"B Odermatt","year":"1991","unstructured":"Odermatt, B., Eppler, M., Leist, T. P., Hengartner, H. & Zinkernagel, R. M. Virus-triggered acquired immunodeficiency by cytotoxic T cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl Acad. Sci. USA 88, 8252\u20138256 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1077_CR44","doi-asserted-by":"publisher","first-page":"e1000080","DOI":"10.1371\/journal.pbio.1000080","volume":"7","author":"A Bergthaler","year":"2009","unstructured":"Bergthaler, A. et al. Impaired antibody response causes persistence of prototypic T cell-contained virus. PLoS Biol. 7, e1000080 (2009).","journal-title":"PLoS Biol."},{"key":"1077_CR45","doi-asserted-by":"publisher","first-page":"e1005456","DOI":"10.1371\/journal.ppat.1005456","volume":"12","author":"AE Mahan","year":"2016","unstructured":"Mahan, A. E. et al. Antigen-specific antibody glycosylation is regulated via vaccination. PLoS Pathog. 12, e1005456 (2016).","journal-title":"PLoS Pathog."},{"key":"1077_CR46","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1182\/bloodadvances.2017011411","volume":"1","author":"JR Francica","year":"2017","unstructured":"Francica, J. R. et al. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Adv. 1, 2329\u20132342 (2017).","journal-title":"Blood Adv."},{"key":"1077_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell, A. J. et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101\u2013104 (2007).","journal-title":"Nature"},{"key":"1077_CR48","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1126\/science.1118948","volume":"310","author":"F Nimmerjahn","year":"2005","unstructured":"Nimmerjahn, F. & Ravetch, J. V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310, 1510\u20131512 (2005).","journal-title":"Science"},{"key":"1077_CR49","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","volume":"278","author":"T Shinkawa","year":"2003","unstructured":"Shinkawa, T. et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278, 3466\u20133473 (2003).","journal-title":"J. Biol. Chem."},{"key":"1077_CR50","doi-asserted-by":"publisher","unstructured":"Wieland, A. et al. Enhancing Fc\u03b3R-mediated antibody effector function during persistent viral infection. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aao3125 (2018).","DOI":"10.1126\/sciimmunol.aao3125"},{"key":"1077_CR51","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/eji.201747208","volume":"47","author":"D Kao","year":"2017","unstructured":"Kao, D. et al. IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice. Eur. J. Immunol. 47, 2070\u20132079 (2017).","journal-title":"Eur. J. Immunol."},{"key":"1077_CR52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1084\/jem.20091777","volume":"207","author":"D Zotos","year":"2010","unstructured":"Zotos, D. et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207, 365\u2013378 (2010).","journal-title":"J. Exp. Med."},{"key":"1077_CR53","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.4049\/jimmunol.177.8.5236","volume":"177","author":"KL Good","year":"2006","unstructured":"Good, K. L., Bryant, V. L. & Tangye, S. G. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177, 5236\u20135247 (2006).","journal-title":"J. Immunol."},{"key":"1077_CR54","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1182\/blood-2009-08-239996","volume":"115","author":"KA Sarosiek","year":"2010","unstructured":"Sarosiek, K. A. et al. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood 115, 570\u2013580 (2010).","journal-title":"Blood"},{"key":"1077_CR55","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.1174182","volume":"324","author":"H Elsaesser","year":"2009","unstructured":"Elsaesser, H., Sauer, K. & Brooks, D. G. IL-21 is required to control chronic viral infection. Science 324, 1569\u20131572 (2009).","journal-title":"Science"},{"key":"1077_CR56","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.4049\/jimmunol.179.10.6808","volume":"179","author":"D Bhattacharya","year":"2007","unstructured":"Bhattacharya, D. et al. Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation. J. Immunol. 179, 6808\u20136819 (2007).","journal-title":"J. Immunol."},{"key":"1077_CR57","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/15384101.2018.1469872","volume":"17","author":"Y Kong","year":"2018","unstructured":"Kong, Y. et al. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. Cell Cycle 17, 1199\u20131211 (2018).","journal-title":"Cell Cycle"},{"key":"1077_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/1535-7163.MCT-17-0574","volume":"17","author":"A Dey","year":"2018","unstructured":"Dey, A. et al. Evaluating the mechanism and therapeutic potential of PTC-028, a novel inhibitor of BMI-1 function in ovarian cancer. Mol. Cancer Ther. 17, 39\u201349 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"1077_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri1783","volume":"6","author":"L Hangartner","year":"2006","unstructured":"Hangartner, L., Zinkernagel, R. M. & Hengartner, H. Antiviral antibody responses: the two extremes of a wide spectrum. Nat. Rev. Immunol. 6, 231\u2013243 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"1077_CR60","doi-asserted-by":"publisher","unstructured":"Lofano, G. et al. Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aat7796 (2018).","DOI":"10.1126\/sciimmunol.aat7796"},{"key":"1077_CR61","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/febs.12299","volume":"280","author":"HB Wang","year":"2013","unstructured":"Wang, H. B. et al. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma. FEBS J. 280, 2929\u20132944 (2013).","journal-title":"FEBS J."},{"key":"1077_CR62","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1096\/fj.11-185033","volume":"25","author":"R Huang","year":"2011","unstructured":"Huang, R. et al. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. FASEB J. 25, 4138\u20134149 (2011).","journal-title":"FASEB J."},{"key":"1077_CR63","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1074\/jbc.M112.422931","volume":"288","author":"JH Cho","year":"2013","unstructured":"Cho, J. H., Dimri, M. & Dimri, G. P. A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway. J. Biol. Chem. 288, 3406\u20133418 (2013).","journal-title":"J. Biol. Chem."},{"key":"1077_CR64","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.1208421","volume":"334","author":"JA Harker","year":"2011","unstructured":"Harker, J. A., Lewis, G. M., Mack, L. & Zuniga, E. I. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334, 825\u2013829 (2011).","journal-title":"Science"},{"key":"1077_CR65","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202\u2013207 (2013).","journal-title":"Science"},{"key":"1077_CR66","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.celrep.2019.12.023","volume":"30","author":"B Fallet","year":"2020","unstructured":"Fallet, B. et al. Chronic viral infection promotes efficient germinal center B cell responses. Cell Rep. 30, 1013\u20131026 (2020).","journal-title":"Cell Rep."},{"key":"1077_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nrd3674","volume":"11","author":"CH Arrowsmith","year":"2012","unstructured":"Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K. & Schapira, M. Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov. 11, 384\u2013400 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1077_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0223-4","volume":"8","author":"L Morera","year":"2016","unstructured":"Morera, L., Lubbert, M. & Jung, M. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Clin. Epigenetics 8, 57 (2016).","journal-title":"Clin. Epigenetics"},{"key":"1077_CR69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneph.2016.20","volume":"12","author":"F Hiepe","year":"2016","unstructured":"Hiepe, F. & Radbruch, A. Plasma cells as an innovative target in autoimmune disease with renal manifestations. Nat. Rev. Nephrol. 12, 232\u2013240 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"1077_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12388","volume":"270","author":"M Low","year":"2016","unstructured":"Low, M., Infantino, S., Grigoriadis, G. & Tarlinton, D. Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells? Immunol. Rev. 270, 78\u201394 (2016).","journal-title":"Immunol. Rev."},{"key":"1077_CR71","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.immuni.2008.04.014","volume":"28","author":"K Kwon","year":"2008","unstructured":"Kwon, K. et al. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity 28, 751\u2013762 (2008).","journal-title":"Immunity"},{"key":"1077_CR72","doi-asserted-by":"publisher","first-page":"e02669","DOI":"10.7554\/eLife.02669","volume":"3","author":"JK Mich","year":"2014","unstructured":"Mich, J. K. et al. Prospective identification of functionally distinct stem cells and neurosphere-initiating cells in adult mouse forebrain. eLife 3, e02669 (2014).","journal-title":"eLife"},{"key":"1077_CR73","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ng.165","volume":"40","author":"E Sangiorgi","year":"2008","unstructured":"Sangiorgi, E. & Capecchi, M. R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40, 915\u2013920 (2008).","journal-title":"Nat. Genet."},{"key":"1077_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-213X-1-4","volume":"1","author":"S Srinivas","year":"2001","unstructured":"Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).","journal-title":"BMC Dev. Biol."},{"key":"1077_CR75","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/nar\/gkl119","volume":"34","author":"K Nowak","year":"2006","unstructured":"Nowak, K. et al. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res. 34, 1745\u20131754 (2006).","journal-title":"Nucleic Acids Res."},{"key":"1077_CR76","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2014.11.001","volume":"41","author":"BE Russ","year":"2014","unstructured":"Russ, B. E. et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation. Immunity 41, 853\u2013865 (2014).","journal-title":"Immunity"},{"key":"1077_CR77","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","volume":"190","author":"A Lux","year":"2013","unstructured":"Lux, A., Yu, X., Scanlan, C. N. & Nimmerjahn, F. Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs. J. Immunol. 190, 4315\u20134323 (2013).","journal-title":"J. Immunol."},{"key":"1077_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16633-7","volume":"11","author":"KM Quinn","year":"2020","unstructured":"Quinn, K. M. et al. Metabolic characteristics of CD8(+) T cell subsets in young and aged individuals are not predictive of functionality. Nat. Commun. 11, 2857 (2020).","journal-title":"Nat. Commun."},{"key":"1077_CR79","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","volume":"33","author":"M Battegay","year":"1991","unstructured":"Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33, 191\u2013198 (1991).","journal-title":"J. Virol. Methods"},{"key":"1077_CR80","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3389\/fimmu.2019.02415","volume":"10","author":"E Lopez","year":"2019","unstructured":"Lopez, E. et al. Low pH exposure during immunoglobulin G purification methods results in aggregates that avidly bind fc\u03b3 receptors: implications for measuring Fc dependent antibody functions. Front. Immunol. 10, 2415 (2019).","journal-title":"Front. Immunol."},{"key":"1077_CR81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jim.2014.12.004","volume":"417","author":"AE Mahan","year":"2015","unstructured":"Mahan, A. E. et al. A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. J. Immunol. Methods 417, 34\u201344 (2015).","journal-title":"J. Immunol. Methods"},{"key":"1077_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/srep27030","volume":"6","author":"CD Scharer","year":"2016","unstructured":"Scharer, C. D. et al. ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naive SLE B cells. Sci. Rep. 6, 27030 (2016).","journal-title":"Sci. Rep."},{"key":"1077_CR83","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"1077_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"1077_CR85","doi-asserted-by":"publisher","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","volume":"9","author":"M Lawrence","year":"2013","unstructured":"Lawrence, M. et al. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 9, e1003118 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"1077_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1077_CR87","doi-asserted-by":"publisher","unstructured":"Powell, D. Degust: interactive RNA-seq analysis. Zenodo https:\/\/doi.org\/10.5281\/zenodo.3258932 (2015).","DOI":"10.5281\/zenodo.3258932"},{"key":"1077_CR88","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.09.010","volume":"143","author":"J Kim","year":"2010","unstructured":"Kim, J. et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143, 313\u2013324 (2010).","journal-title":"Cell"},{"key":"1077_CR89","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/nar\/29.2.397","volume":"29","author":"M Schuhmacher","year":"2001","unstructured":"Schuhmacher, M. et al. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29, 397\u2013406 (2001).","journal-title":"Nucleic Acids Res."},{"key":"1077_CR90","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.03.030","volume":"23","author":"G Gargiulo","year":"2013","unstructured":"Gargiulo, G. et al. In vivo RNAi screen for BMI1 targets identifies TGF-\u03b2\/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis. Cancer Cell 23, 660\u2013676 (2013).","journal-title":"Cancer Cell"},{"key":"1077_CR91","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1158\/0008-5472.CAN-07-6152","volume":"68","author":"D Douglas","year":"2008","unstructured":"Douglas, D. et al. BMI-1 promotes Ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res. 68, 6507\u20136515 (2008).","journal-title":"Cancer Res."},{"key":"1077_CR92","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1128\/MCB.02244-06","volume":"27","author":"D Wiederschain","year":"2007","unstructured":"Wiederschain, D. et al. Contribution of Polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol. Cell. Biol. 27, 4968\u20134979 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"1077_CR93","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/sj.onc.1210774","volume":"27","author":"M Nuytten","year":"2008","unstructured":"Nuytten, M. et al. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. Oncogene 27, 1449\u20131460 (2008).","journal-title":"Oncogene"},{"key":"1077_CR94","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.celrep.2017.03.060","volume":"19","author":"D Piovesan","year":"2017","unstructured":"Piovesan, D. et al. c-Myb regulates the T-Bet-dependent differentiation program in B cells to coordinate antibody responses. Cell Rep. 19, 461\u2013470 (2017).","journal-title":"Cell Rep."},{"key":"1077_CR95","doi-asserted-by":"publisher","unstructured":"Staupe, R. P. et al. Chronic viral infection promotes early germinal center exit of B cells and impaired antibody development. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/849844 (2019).","DOI":"10.1101\/849844"},{"key":"1077_CR96","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/bioinformatics\/btw593","volume":"33","author":"AM Rosenfeld","year":"2017","unstructured":"Rosenfeld, A. M., Meng, W., Luning Prak, E. T. & Hershberg, U. ImmuneDB: a system for the analysis and exploration of high-throughput adaptive immune receptor sequencing data. Bioinformatics 33, 292\u2013293 (2017).","journal-title":"Bioinformatics"},{"key":"1077_CR97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jim.2015.10.009","volume":"427","author":"B Zhang","year":"2015","unstructured":"Zhang, B., Meng, W., Luning Prak, E. T. & Hershberg, U. Discrimination of germline V genes at different sequencing lengths and mutational burdens: a new tool for identifying and evaluating the reliability of V gene assignment. J. Immunol. Methods 427, 105\u2013116 (2015).","journal-title":"J. Immunol. Methods"},{"key":"1077_CR98","first-page":"695","volume":"2011","author":"V Giudicelli","year":"2011","unstructured":"Giudicelli, V., Brochet, X. & Lefranc, M. P. IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb. Protoc. 2011, 695\u2013715 (2011).","journal-title":"Cold Spring Harb. Protoc."},{"key":"1077_CR99","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1093\/nar\/gks457","volume":"40","author":"G Yaari","year":"2012","unstructured":"Yaari, G., Uduman, M. & Kleinstein, S. H. Quantifying selection in high-throughput Immunoglobulin sequencing data sets. Nucleic Acids Res. 40, e134 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1077_CR100","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"1077_CR101","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20150191","volume":"212","author":"KL Good-Jacobson","year":"2015","unstructured":"Good-Jacobson, K. L., O\u2019Donnell, K., Belz, G. T., Nutt, S. L. & Tarlinton, D. M. c-Myb is required for plasma cell migration to bone marrow after immunization or infection. J. Exp. Med. 212, 1001\u20131009 (2015).","journal-title":"J. Exp. Med."},{"key":"1077_CR102","doi-asserted-by":"publisher","first-page":"583","DOI":"10.21105\/joss.00583","volume":"3","author":"K Tsyganov","year":"2018","unstructured":"Tsyganov, K., Perry, A. J., Archer, S. K. & Powell, D. RNAsik: a pipeline for complete and reproducible RNA-seq analysis that runs anywhere with speed and ease. J. Open Source Softw. 3, 583 (2018).","journal-title":"J. Open Source Softw."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01077-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01077-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01077-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:49:34Z","timestamp":1733957374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01077-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1038\/s41590-021-01077-y","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L.G.-J. has received funding from GSK for a separate project. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}